Assyro AI

Orange Book product · Brand (NDA)

ROCKLATAN

LATANOPROST; NETARSUDIL DIMESYLATE

Brand (NDA)NDA 208259RX ALCON LABS INC
View LATANOPROST; NETARSUDIL DIMESYLATE familyOpen on FDA Orange Book

At a glance

Mar 12, 2019

Approved

Brand (NDA)

Application

Not listed

TE code

17

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 12, 2019

    7 yr 5 mo ago

  2. Today

  3. Patent 10532993 expires

    Listed method-of-use patent (U-1524) expiration.

    Jul 11, 2026

    in 22 d

  4. Patent 10882840 expires

    Listed method-of-use patent (U-1524) expiration.

    Jul 11, 2026

    in 22 d

  5. Patent 11021456 expires

    Listed method-of-use patent (U-1524) expiration.

    Jul 11, 2026

    in 22 d

  6. Patent 8450344 expires

    Listed drug substance patent expiration.

    Jul 11, 2026

    in 22 d

  7. Patent 9096569 expires

    Listed drug substance patent expiration.

    Jul 11, 2026

    in 22 d

  8. Patent 10174017 expires

    Listed drug substance patent expiration.

    Jan 27, 2030

    in 3 yr 8 mo

  9. Patent 10654844 expires

    Listed drug substance patent expiration.

    Jan 27, 2030

    in 3 yr 8 mo

  10. Patent 11028081 expires

    Listed method-of-use patent (U-1524) expiration.

    Jan 27, 2030

    in 3 yr 8 mo

  11. Patent 11618748 expires

    Listed method-of-use patent (U-1524) expiration.

    Jan 27, 2030

    in 3 yr 8 mo

  12. Patent 8394826 expires

    Listed drug substance patent expiration.

    Nov 10, 2030

    in 4 yr 6 mo

  13. Patent 10588901 expires

    Listed drug substance patent expiration.

    Mar 14, 2034

    in 7 yr 10 mo

  14. Patent 11020385 expires

    Listed method-of-use patent (U-1524) expiration.

    Mar 14, 2034

    in 7 yr 10 mo

  15. Patent 11185538 expires

    Listed drug product patent expiration.

    Mar 14, 2034

    in 7 yr 10 mo

  16. Patent 11197853 expires

    Listed drug product patent expiration.

    Mar 14, 2034

    in 7 yr 10 mo

  17. Patent 9415043 expires

    Listed drug substance patent expiration.

    Mar 14, 2034

    in 7 yr 10 mo

  18. Patent 9931336 expires

    Listed drug substance patent expiration.

    Mar 14, 2034

    in 7 yr 10 mo

  19. Patent 9993470 expires

    Listed drug substance patent expiration.

    Mar 14, 2034

    in 7 yr 10 mo

Pharmaceutical detail

Active ingredient

LATANOPROST; NETARSUDIL DIMESYLATE

Strength

0.005%;EQ 0.02% BASE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 208259

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (17)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10532993Jul 11, 2026in 22 d
U-1524
10882840Jul 11, 2026in 22 d
U-1524
11021456Jul 11, 2026in 22 d
U-1524
8450344Jul 11, 2026in 22 d
SubstanceProductU-1524
9096569Jul 11, 2026in 22 d
SubstanceProductU-1524
10174017Jan 27, 2030in 3 yr 8 mo
SubstanceProductU-1524
10654844Jan 27, 2030in 3 yr 8 mo
SubstanceProductU-1524
11028081Jan 27, 2030in 3 yr 8 mo
U-1524
11618748Jan 27, 2030in 3 yr 8 mo
U-1524
8394826Nov 10, 2030in 4 yr 6 mo
SubstanceProductU-1524
10588901Mar 14, 2034in 7 yr 10 mo
SubstanceProductU-1524
11020385Mar 14, 2034in 7 yr 10 mo
U-1524
11185538Mar 14, 2034in 7 yr 10 mo
Product
11197853Mar 14, 2034in 7 yr 10 mo
Product
9415043Mar 14, 2034in 7 yr 10 mo
Substance
9931336Mar 14, 2034in 7 yr 10 mo
SubstanceProductU-1524
9993470Mar 14, 2034in 7 yr 10 mo
SubstanceProductU-1524
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo